NasdaqGS - Nasdaq Real Time Price USD

Olema Pharmaceuticals, Inc. (OLMA)

9.52 -0.32 (-3.25%)
At close: 4:00 PM EDT
9.52 0.00 (0.00%)
After hours: 4:02 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
109,698.00
104,961.00
106,988.00
71,491.00
21,528.00
Operating Income
-109,698.00
-104,961.00
-106,988.00
-71,491.00
-21,528.00
Net Non Operating Interest Income Expense
10,372.00
8,325.00
2,228.00
442.00
-593.00
Other Income Expense
-13.00
-19.00
-27.00
-47.00
--
Pretax Income
-99,339.00
-96,655.00
-104,787.00
-71,096.00
-22,121.00
Net Income Common Stockholders
-99,339.00
-96,655.00
-104,787.00
-71,096.00
-23,990.00
Diluted NI Available to Com Stockholders
-99,339.00
-96,655.00
-104,787.00
-71,096.00
-23,990.00
Basic EPS
-2.00
--
-2.62
-1.80
-3.42
Diluted EPS
-2.00
--
-2.62
-1.80
-3.42
Basic Average Shares
49,052.06
--
39,995.46
39,524.27
7,021.47
Diluted Average Shares
49,052.06
--
39,995.46
39,524.27
7,021.47
Total Operating Income as Reported
-109,698.00
-104,961.00
-106,988.00
-71,491.00
-21,528.00
Total Expenses
109,698.00
104,961.00
106,988.00
71,491.00
21,528.00
Net Income from Continuing & Discontinued Operation
-99,339.00
-96,655.00
-104,787.00
-71,096.00
-22,121.00
Normalized Income
-99,339.00
-96,655.00
-104,787.00
-71,096.00
-22,121.00
Interest Income
10,372.00
8,325.00
2,228.00
442.00
60.00
Interest Expense
--
--
--
--
653.00
Net Interest Income
10,372.00
8,325.00
2,228.00
442.00
-593.00
EBIT
-109,698.00
-104,961.00
-106,988.00
-71,491.00
-21,468.00
EBITDA
-109,333.00
-104,584.00
-106,631.00
-71,328.00
-21,457.00
Reconciled Depreciation
365.00
377.00
357.00
163.00
11.00
Net Income from Continuing Operation Net Minority Interest
-99,339.00
-96,655.00
-104,787.00
-71,096.00
-22,121.00
Normalized EBITDA
-109,333.00
-104,584.00
-106,631.00
-71,328.00
-21,457.00
12/31/2020 - 11/19/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MLYS Mineralys Therapeutics, Inc.
12.81
-1.46%
 
IMTX Immatics N.V.
10.94
-0.18%
 
ERAS Erasca, Inc.
2.2400
+13.71%
 
ARVN Arvinas, Inc.
33.26
+1.77%
 
FULC Fulcrum Therapeutics, Inc.
7.70
+1.99%
 
CGON CG Oncology, Inc.
29.73
-0.83%
 
PRAX Praxis Precision Medicines, Inc.
45.01
-0.84%
 
PLRX Pliant Therapeutics, Inc.
15.12
-0.98%
 
APGE Apogee Therapeutics, Inc.
52.42
+4.19%
 
CYTK Cytokinetics, Incorporated
60.60
+1.80%